Company Information
CIN
Status
Date of Incorporation
12 November 2012
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
100,000
Authorised Capital
20,000,000
Directors
Venkata Nookaraju Sreedharala
Director/Designated Partner
over 2 years ago
over 2 years ago
Nookala Venkata Satya Surya Lakshmi Narayana
Director/Designated Partner
over 9 years ago
over 9 years ago
Past Directors
Sree Rama Chandra Varma Gottimukkala
Additional Director
over 5 years ago
over 5 years ago
Patents
The present invention relates to topical pharmaceutical compositions of apremilast used for the treatment of psoriasis and/or psoriatic arthritis. It further relates to processes of preparation of the compositions and the method of use for these compositions.
Abstract
The present invention relates to topical compositions comprising apremilast. It also relates to processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatosis, eczema, rosacea, acne vulgaris, allergies, contact and atopic dermat...
The present invention provides a topical composition of Apremilast with lipohilic agents. The plurality of excipients each present in amounts, and in combination, to effectively control the release of Apremilast from the composition for better penetration in to the skin. The present invention also provides a process...
The present invention relates to a novel topical pharmaceutical composition of Teriflunomide, methods of preparing such compositions for long term storage stability, and use thereof for relieving the symptoms of pain and arthritis in subjects suffering from autoimmune diseases like multiple sclerosis or rheumatoid a...
ABSTRACT
STABLE AMORPHOUS ELIGLUSTAT PREMIX
AND PROCESS FOR THE PREPARATION THEREOF
The present invention relates to pharmaceutical compositions of Eliglustat. In particular the present invention relates to stable amorphous Eliglustat premix, method of preparation of the same and pharmaceutical compositions ...
The present invention relates to simple and stable pharmaceutical compositions comprising an effective amount of Diclofenac. The present invention provides solidoral dosage forms containing Diclofenac or pharmaceutically acceptable salts or derivatives thereof in a relatively low dose; and simple and inexpensive met...
The present invention provides a low dose topical composition of Apremilast with pharmaceutically acceptable excipients. The present invention also relates to a topical clear gel composition of apremilast for delivering a desired therapeutic amount of drug to the site of action after topical application. The present...
ABSTRACT
IMPROVED AND STABLE APREMILAST PHARMACEUTICAL
COMPOSITIONS
The present invention relates to an improved and stable topical pharmaceutical
compositions of apremilast used for the treatment of psoriasis and/or psoriatic
arthritis. It further relates to processes of preparation of the stable compositions
...
Documents
Form DIR-12-09102020_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-08102020
Evidence of cessation;-08102020
Notice of resignation;-08102020
Optional Attachment-(1)-08102020
Form DPT-3-03062020-signed
Form AOC-4-31102019_signed
Form MGT-7-31102019_signed
List of share holders, debenture holders;-24102019
Directors report as per section 134(3)-24102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-24102019
Form ADT-1-12102019_signed
Copy of written consent given by auditor-11102019
Copy of the intimation sent by company-11102019
Copy of resolution passed by the company-11102019
Form DPT-3-27062019
Form INC-22-18042019_signed
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-18042019
Optional Attachment-(1)-18042019
Copies of the utility bills as mentioned above (not older than two months)-18042019
Copy of board resolution authorizing giving of notice-18042019
Form MGT-7-19112018_signed
List of share holders, debenture holders;-13112018
Directors report as per section 134(3)-25102018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25102018
Form AOC-4-25102018_signed
Form DIR-12-21042018_signed
Optional Attachment-(2)-19042018
Optional Attachment-(1)-19042018
Interest in other entities;-19042018
